Trial · NCT02683239
Adverse events3,192
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 3,192
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Fasinumab-matching Placebo Q4W/Q8W | 413 | 1,257 | 771 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Fasinumab 1mg SC Q8W | 347 | 966 | 636 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Fasinumab 1mg SC Q4W | 350 | 974 | 633 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Fasinumab 3mg SC Q4W | 69 | 214 | 109 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Fasinumab 6mg SC Q8W | 710 | 1,677 | 1,358 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Fasinumab 6mg SC Q4W | 53 | 116 | 115 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Fasinumab 9mg SC Q4W | 45 | 115 | 82 |
| other | Back pain | Musculoskeletal and connective tissue disorders | Fasinumab-matching Placebo Q4W/Q8W | 204 | 1,257 | 363 |
| other | Back pain | Musculoskeletal and connective tissue disorders | Fasinumab 1mg SC Q8W | 207 | 966 | 336 |
| other | Back pain | Musculoskeletal and connective tissue disorders | Fasinumab 1mg SC Q4W | 185 | 974 | 301 |
| other | Back pain | Musculoskeletal and connective tissue disorders | Fasinumab 3mg SC Q4W | 30 | 214 | 37 |
| other | Back pain | Musculoskeletal and connective tissue disorders | Fasinumab 6mg SC Q8W | 283 | 1,677 | 519 |
| other | Back pain | Musculoskeletal and connective tissue disorders | Fasinumab 6mg SC Q4W | 14 | 116 | 24 |
| other | Back pain | Musculoskeletal and connective tissue disorders | Fasinumab 9mg SC Q4W | 13 | 115 | 18 |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Fasinumab-matching Placebo Q4W/Q8W | 113 | 1,257 | 151 |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Fasinumab 1mg SC Q8W | 114 | 966 | 144 |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Fasinumab 1mg SC Q4W | 124 | 974 | 181 |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Fasinumab 3mg SC Q4W | 16 | 214 | 31 |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Fasinumab 6mg SC Q8W | 151 | 1,677 | 215 |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Fasinumab 6mg SC Q4W | 20 | 116 | 29 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02683239/events